Disclaimer: This article was published in 2023 and reflects the information available at that time.
  Off-label prescribing occurs when a medication is used for a purpose that is not approved by the Australian Therapeutic Goods Administration (TGA). It may involve using a medication in a different dosage, route of administration or for a different patient population. While off-label pres…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article
Mounjaro® (tirzepatide)
9 November 2023
NationalDispensingProfessional activitiesPrivacy and consent
Learn more